Allarity Therapeutics (ALLR) Stock Statistics & Valuation Metrics

Allarity Therapeutics has a market cap or net worth of $18.35M. The enterprise value is $5.37M.

Allarity Therapeutics has 15,818,980 shares outstanding. The number of shares has decreased by -2.65% in one year.

Allarity Therapeutics’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -112.26%.

The current PE Ratio of Allarity Therapeutics is ―. Allarity Therapeutics’s PEG ratio is 0.00.

In the last 12 months, Allarity Therapeutics had revenue of 320.00K and earned -11.23M in profits. Earnings per share was -0.78.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Allarity Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Allarity Therapeutics upcoming earnings date is May 22, 2026, After Close (Confirmed).

Allarity Therapeutics as a current ratio of 2.13, with Debt / Equity ratio of 14.25%

In the past 12 months, Allarity Therapeutics has paid 0.00 in taxes.

Allarity Therapeutics EV to EBITDA ratio is -0.20, with an EV/FCF ratio of -0.15.

Allarity Therapeutics has $14.69M in cash and marketable securities with $1.40M in debt, giving a net cash position of $13.29M billion.

Gross margin is 100.00%, with operating margin of -3939.06%, and net profit margin of -3509.69%.

The average price target for Allarity Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―